823 related articles for article (PubMed ID: 16203864)
1. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
Gattinoni L; Finkelstein SE; Klebanoff CA; Antony PA; Palmer DC; Spiess PJ; Hwang LN; Yu Z; Wrzesinski C; Heimann DM; Surh CD; Rosenberg SA; Restifo NP
J Exp Med; 2005 Oct; 202(7):907-12. PubMed ID: 16203864
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8
Johnson CB; May BR; Riesenberg BP; Suriano S; Mehrotra S; Garrett-Mayer E; Salem ML; Jeng EK; Wong HC; Paulos CM; Wrangle JM; Cole DJ; Rubinstein MP
Cancer Res; 2018 Jun; 78(11):3067-3074. PubMed ID: 29636345
[TBL] [Abstract][Full Text] [Related]
3. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.
Paulos CM; Wrzesinski C; Kaiser A; Hinrichs CS; Chieppa M; Cassard L; Palmer DC; Boni A; Muranski P; Yu Z; Gattinoni L; Antony PA; Rosenberg SA; Restifo NP
J Clin Invest; 2007 Aug; 117(8):2197-204. PubMed ID: 17657310
[TBL] [Abstract][Full Text] [Related]
4. Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.
Wrzesinski C; Paulos CM; Kaiser A; Muranski P; Palmer DC; Gattinoni L; Yu Z; Rosenberg SA; Restifo NP
J Immunother; 2010 Jan; 33(1):1-7. PubMed ID: 19952961
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lymphodepletion on Donor T Cells and the Role of Recipient Cells Persisting after Cytotoxic Treatments in Cancer Immunotherapies.
Watanabe S; Arita M; Takahashi M; Saida Y; Koya T; Kikuchi T
Crit Rev Immunol; 2017; 37(1):59-73. PubMed ID: 29431079
[TBL] [Abstract][Full Text] [Related]
6. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Ji Y; Wrzesinski C; Yu Z; Hu J; Gautam S; Hawk NV; Telford WG; Palmer DC; Franco Z; Sukumar M; Roychoudhuri R; Clever D; Klebanoff CA; Surh CD; Waldmann TA; Restifo NP; Gattinoni L
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):476-81. PubMed ID: 25548153
[TBL] [Abstract][Full Text] [Related]
7. Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.
Tanaka T; Watanabe S; Takahashi M; Sato K; Saida Y; Baba J; Arita M; Sato M; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Aoki N; Ohshima Y; Sakagami T; Abe T; Moro H; Koya T; Tanaka J; Kagamu H; Yoshizawa H; Kikuchi T
PLoS One; 2017; 12(8):e0183976. PubMed ID: 28854279
[TBL] [Abstract][Full Text] [Related]
8. Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.
Kodumudi KN; Weber A; Sarnaik AA; Pilon-Thomas S
J Immunol; 2012 Dec; 189(11):5147-54. PubMed ID: 23100512
[TBL] [Abstract][Full Text] [Related]
9. Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Saida Y; Watanabe S; Tanaka T; Baba J; Sato K; Shoji S; Igarashi N; Kondo R; Okajima M; Koshio J; Ichikawa K; Nozaki K; Ishikawa D; Koya T; Miura S; Tanaka J; Kagamu H; Yoshizawa H; Nakata K; Narita I
J Immunol; 2015 Jul; 195(2):726-35. PubMed ID: 26041539
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
Wrzesinski C; Paulos CM; Gattinoni L; Palmer DC; Kaiser A; Yu Z; Rosenberg SA; Restifo NP
J Clin Invest; 2007 Feb; 117(2):492-501. PubMed ID: 17273561
[TBL] [Abstract][Full Text] [Related]
11. Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.
Ng SSM; Nagy BA; Jensen SM; Hu X; Alicea C; Fox BA; Felber BK; Bergamaschi C; Pavlakis GN
Clin Cancer Res; 2017 Jun; 23(11):2817-2830. PubMed ID: 27986749
[No Abstract] [Full Text] [Related]
12. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.
Antony PA; Piccirillo CA; Akpinarli A; Finkelstein SE; Speiss PJ; Surman DR; Palmer DC; Chan CC; Klebanoff CA; Overwijk WW; Rosenberg SA; Restifo NP
J Immunol; 2005 Mar; 174(5):2591-601. PubMed ID: 15728465
[TBL] [Abstract][Full Text] [Related]
13. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.
Winstead CJ; Fraser JM; Khoruts A
J Immunol; 2008 Jun; 180(11):7305-17. PubMed ID: 18490730
[TBL] [Abstract][Full Text] [Related]
14. Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.
Baba J; Watanabe S; Saida Y; Tanaka T; Miyabayashi T; Koshio J; Ichikawa K; Nozaki K; Koya T; Deguchi K; Tan C; Miura S; Tanaka H; Tanaka J; Kagamu H; Yoshizawa H; Nakata K; Narita I
Blood; 2012 Sep; 120(12):2417-27. PubMed ID: 22806892
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
[TBL] [Abstract][Full Text] [Related]
16. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
[TBL] [Abstract][Full Text] [Related]
17. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
[TBL] [Abstract][Full Text] [Related]
18. PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Takahashi M; Watanabe S; Suzuki R; Arita M; Sato K; Sato M; Sekiya Y; Abe Y; Fujisaki T; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Saida Y; Hokari S; Aoki N; Hayashi M; Ohshima Y; Koya T; Kikuchi T
Cancer Immunol Immunother; 2022 Jun; 71(6):1357-1369. PubMed ID: 34657194
[TBL] [Abstract][Full Text] [Related]
19. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection.
Brown IE; Blank C; Kline J; Kacha AK; Gajewski TF
J Immunol; 2006 Oct; 177(7):4521-9. PubMed ID: 16982889
[TBL] [Abstract][Full Text] [Related]
20. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
Ma J; Wang YL; Hu HM; Fox BA; Si LS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
